Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Gregory J. Glover, MD, a registered patent attorney and non-practicing physician with Pharmaceutical Law Group PC, is one of the nation’s experts on the complex interaction of food and drug laws and intellectual property, including the patent and non-patent provisions of the Drug Price Competition and Patent Term Restoration Act of 1984 (the “Hatch-Waxman Act”). Greg represents life sciences companies, investors, and trade associations on strategic product development issues, including market protection analyses based on intellectual property laws, FDA regulations, and patent portfolio evaluations. Greg has also testified on behalf of the research-based pharmaceutical industry before committees of both houses of Congress on legislative matters affecting market protection for pharmaceutical, biotechnology, and medical device products, and he has made presentations on behalf of research-based companies on market protection issues before the Food and Drug Administration, the Federal Trade Commission, and the Department of Justice. Greg received his A.B. in biochemical sciences from Harvard College and his JD from Harvard Law School. Following law school, he completed medical school at Duke University and served as an intern at New England Deaconess Hospital in Boston, MA.